Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22263800 | 0.83 | KDM4E (0.38) | KDM4EEPHX2ALDH1A1POLBALOX15 | |
| SCHEMBL5873088 | 0.83 | EPHX2 (0.32) | KDM4EEPHX2ALDH1A1 | |
| SCHEMBL22263786 | 0.82 | NAAA (0.44) | KDM4EEPHX2ALDH1A1 | |
| SCHEMBL22263750 | 0.81 | NAAA (0.46) | KDM4EEPHX2ALDH1A1 | |
| SCHEMBL22263863 | 0.81 | NAAA (0.46) | KDM4EEPHX2ALDH1A1 | |
| SCHEMBL4739740 | 0.80 | KDM4E (0.40) | KDM4EEPHX2ALDH1A1POLBALOX15 | |
| SCHEMBL5873043 | 0.78 | ALDH1A1 (0.42) | KDM4EEPHX2ALDH1A1POLBALOX15 | |
| SCHEMBL13888501 | 0.77 | EPHX2 (0.35) | KDM4EEPHX2ALDH1A1POLBALOX15 | |
| SCHEMBL1089531 | 0.77 | KDM4E (0.41) | KDM4EEPHX2ALDH1A1POLBALOX15 | |
| SCHEMBL4379431 | 0.76 | KDM4E (0.38) | KDM4EEPHX2ALDH1A1POLBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7029822-B2 | Tertiary alcohol compounds having alicyclic structure | SHIN ETSU CHEMICAL CO., LTD. (JP) | 2006-04-18 | — | — | US | disclosed |
| US-20040254394-A1 | Novel tertiary alcohol compounds having alicyclic structure | HASEGAWA KOJI (JP) | 2004-12-16 | — | — | US | disclosed |
| US-6774258-B2 | USEFUL AS MONOMER TO FORM POLYMER WHICH SERVES AS A BASE RESIN IN CHEMICALLY AMPLIFIED RESIST | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-08-10 | — | — | US | disclosed |
| US-20020072579-A1 | Novel tertiary alcohol compounds having alicyclic structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254394-A1 | Novel tertiary alcohol compounds having alicyclic structure | ADH1A, ADH1C, ICAM1 | KDM4E 822/4885EPHX2 1285/4885ALDH1A1 30/4885 |
| US-20020072579-A1 | Novel tertiary alcohol compounds having alicyclic structure | ADH1A, ADH1C, ICAM1 | KDM4E 822/4885EPHX2 1285/4885ALDH1A1 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.